Amgen S.A.S.
Corporate group: Amgen Group · HQ: United States
Total cases
2 (1 active)
Claimant-side
1
Respondent-side
1
Not counted above: 1 file-access request (R. 262.1(b) RoP), where someone asked to read a case file. View
Amgen S.A.S. has been party to two Unified Patent Court cases, once as claimant and once as respondent. The most recent on record is UPC CoA 153/2026 at the Court of Appeal, brought by Carpmaels & Ransford LLP. Its most recent decision on the merits was in UPC CFI 505/2023 at the Dusseldorf Local Division on 13 May 2025: no infringement found.